Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

‘Breakthrough’ Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

MOSAEC
Author: MOSAEC

Source: BBC.

Written by

MOSAEC

in

Uncategorized
←‘It’s a Proud Moment’: Stella McCartney on Returning to Collaborate With H&M, 20 Years Later
Play-off pending? How draw at Etihad could set up thrilling finale→

More posts

  • MAD Solutions & IRTH Strike Pan-Arab Development & Production Strategic Partnership – Venice

  • Man Utd made midfield recruitment summer priority – what happens now?

  • Telluride Film Festival 2026: Read All Of Deadline’s Reviews

  • Reform promises to increase tax-free personal allowance to £15,000

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube